Cancer Support Program
The Optum® Cancer Support Program (CSP) is an integrated approach that closes gaps in care. With CSP, members have access to a specialized nurse case manager and support from an entire team of cancer experts.
CSP nurse case managers provide network guidance, education, pain management, treatment adherence, and palliative and end-of-life care.
Ensuring the patient’s condition is properly managed helps avoid hospitalizations, emergency department visits and inappropriate treatment, thus reducing total cost of care for clients.
Cancer Guidance Program
The Cancer Guidance Program (CGP) is an evidence-based cancer treatment, utilization management and analytics service. CGP helps reduce medical expenses associated with a range of high-cost, complex cancer treatments.
CGP supports providers serving over 27 million members across multiple clients. It generates more than a 10:1 ROI by mitigating cost trends, even before implementing value levers such as Pathways and Preferred Products.5
Proven outcomes
- Provider Net Promoter Score: 63
- 79% of requests entered by provider through CGP website
- 92% preferred product adherence
The Specialty Guidance Program (SGP) and CGP are part of the Specialty Medical Guidance Program family. CGP focuses on cancer conditions, while SGP focuses on specialty non-cancer conditions.
Cancer Resource Services
Cancer Resource Services (CRS) provides access to top-performing cancer centers across the country, known as our Cancer Centers of Excellence (COE) network.
The Optum COE network includes 37 leading cancer centers that meet strict evaluation criteria such as:
- A multidisciplinary approach to care
- Program depth and breadth
- Best-practices medicine
- Patient- and family-oriented programs and services
- Patient volumes
- Treatment planning and coordination
- High-quality clinical research
- Patient safety
Learn more about our solutions
Oncology solutions
Oncology trends
Specialty Guidance Program
Sources
- IQVIA. Global oncology trends 2019. May, 2019. Accessed April 27, 2020.
- U.S. Food and Drug Administration. Hematology/oncology (cancer) approvals and safety notifications. Last updated April 22, 2020. Accessed April 27, 2020.
- National Cancer Institute. Cancer statistics. Last updated April 27, 2018. Accessed April 27, 2020.
- 2019–2020 Optum book of business analysis.
- Optum book of business, Nov. 2018–Aug. 2019, for Medicaid client with membership across 11 states.